WarfarinVitamin K Epoxide ReductasesMixed Function OxygenasesAnticoagulantsAryl Hydrocarbon HydroxylasesPhenprocoumonDrug Dosage CalculationsTiclopidineAcenocoumarolPharmacogeneticsPlatelet Aggregation InhibitorsInternational Normalized RatioDrug Administration ScheduleDose-Response Relationship, DrugMethimazoleReceptors, Purinergic P2Y12Administration, OralMethadyl AcetatePropylthiouracilThiophenesTreatment OutcomeDouble-Blind MethodAspirinTime FactorsHalf-LifeDrug InteractionsAntithyroid AgentsImmunoglobulins, Thyroid-StimulatingDrug Therapy, CombinationHemorrhageProthrombin TimeAtrial FibrillationThromboembolismPurinergic P2 Receptor AntagonistsPlatelet Function TestsProspective StudiesAmiodaroneBudesonidebeta-AlaninePrednisolonePlatelet AggregationVitamin KGraves DiseaseRecurrenceGenotypeEthanolamines